SARAH LASHWAY: Open Payments
NPI 1386296747 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 40 payments from 12 companies in 2025. Trend: 2023 $390 · 2024 $838 · 2025 $846
Food & beverage: $586Education: $260
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $165 |
| Janssen Biotech, Inc. | 5 | $164 |
| Daiichi Sankyo Inc. | 16 | $162 |
| Astellas Pharma US Inc | 4 | $141 |
| Celgene Corporation | 3 | $56 |
| BeiGene USA, Inc. | 1 | $33 |
| AVYXA PHARMA, LLC | 1 | $32 |
| ABBVIE INC. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $19 |
Products named: ERLEADA, Enhertu, Padcev, RYBREVANT, INJECTAFER, REBLOZYL, JAKAFI, BRUKINSA.
Industry payments across NY — which companies pay providers there.
